The article discusses the mechanisms of hepatic fibrogenesis, focusing on the activation of hepatic stellate cells and other fibrogenic populations, including portal fibroblasts, fibrocytes, and bone-marrow-derived cells. It highlights the role of stellate cells in inflammation and immunity, the pathways controlling gene expression during stellate cell activation, disease-specific fibrogenesis pathways, and the importance of matrix cross-linking and scar maturation in fibrosis resolution. It also explores the potential contribution of stellate cells to hepatic stem cell behavior, cancer, and regeneration. The article emphasizes the clinical and translational implications of these advances, including the impact on the management and prognosis of chronic liver disease. It discusses the role of various mediators, such as reactive oxygen species, apoptosis, and inflammatory signals, in fibrogenesis. The article also covers the cellular sources of extracellular matrix (ECM) in hepatic fibrosis, the pathways of stellate cell activation, and the role of stellate cells in matrix degradation and fibrosis resolution. It highlights the disease-specific pathways of fibrosis in conditions such as non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), and hepatitis C virus (HCV) infection. The article also discusses the links between stellate cells and progenitor cells, fibrosis, and cancer, as well as the clinical and translational implications of these findings. The article concludes with the importance of continued research into the mechanisms of hepatic fibrogenesis for improving the diagnosis, treatment, and prognosis of chronic liver disease.The article discusses the mechanisms of hepatic fibrogenesis, focusing on the activation of hepatic stellate cells and other fibrogenic populations, including portal fibroblasts, fibrocytes, and bone-marrow-derived cells. It highlights the role of stellate cells in inflammation and immunity, the pathways controlling gene expression during stellate cell activation, disease-specific fibrogenesis pathways, and the importance of matrix cross-linking and scar maturation in fibrosis resolution. It also explores the potential contribution of stellate cells to hepatic stem cell behavior, cancer, and regeneration. The article emphasizes the clinical and translational implications of these advances, including the impact on the management and prognosis of chronic liver disease. It discusses the role of various mediators, such as reactive oxygen species, apoptosis, and inflammatory signals, in fibrogenesis. The article also covers the cellular sources of extracellular matrix (ECM) in hepatic fibrosis, the pathways of stellate cell activation, and the role of stellate cells in matrix degradation and fibrosis resolution. It highlights the disease-specific pathways of fibrosis in conditions such as non-alcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), and hepatitis C virus (HCV) infection. The article also discusses the links between stellate cells and progenitor cells, fibrosis, and cancer, as well as the clinical and translational implications of these findings. The article concludes with the importance of continued research into the mechanisms of hepatic fibrogenesis for improving the diagnosis, treatment, and prognosis of chronic liver disease.